January 22, 2026
1 min read

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes

Abbott Laboratories stock fell Thursday after the medical-products maker reporting disappointing results, hit by a slump in the division that makes baby formula and nutrition shakes.
Fourth-quarter sales in the nutrition business, which includes Similac baby formula and Ensure drinks, dropped 8.9%

Leave a Reply

Your email address will not be published.

Previous Story

Global pharma manufacturing output surged in ’25 in ‘front-loading’ response to US tariff threats: report

Next Story

Guinea-Bissau says plans for controversial U.S.-funded vaccine study need further review

Previous Story

Global pharma manufacturing output surged in ’25 in ‘front-loading’ response to US tariff threats: report

Next Story

Guinea-Bissau says plans for controversial U.S.-funded vaccine study need further review

Latest from Blog

Go toTop